Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342)

OBJECTIVES: The multinational PEARLS (ACTG A5175) study, conducted mainly in resource-limited settings, identified an increased treatment failure rate among HIV-infected individuals randomized to once-daily unboosted atazanavir, didanosine-EC, and emtricitabine compared with efavirenz-based regimens...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Antimicrob Chemother
Autori principali: Castillo-Mancilla, Jose R., Aquilante, Christina L., Wempe, Michael F., Smeaton, Laura M., Firnhaber, Cynthia, LaRosa, Alberto M., Kumarasamy, Nagalingeswaran, Andrade, Adriana, Baheti, Gautam, Fletcher, Courtney V., Campbell, Thomas B., Haas, David W., MaWhinney, Samantha, Anderson, Peter L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2016
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4867099/
https://ncbi.nlm.nih.gov/pubmed/26892777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi